Global Acne Medication Market 2021

January 2022 | 15 pages | ID: G264B5FCFBE1EN
StrategyHelix Inc

Abstracts

Acne is a common skin condition causing pimples and other abnormalities on the face and upper torso. Acne is caused by an interaction between hormones, skin oils, and bacteria, which results in inflammation of hair follicles (the pores in the skin where hair grows). The global acne medication market is poised to grow by US$ 2,184 million during 2021-2027, progressing at a CAGR of 5.2% during the forecast period, according to data and analytics company StrategyHelix. Increasing sedentary lifestyle and unhealthy food habits, increasing prevalence of acne and facial skin diseases, rise in adoption of skin care products, growing acne cases in geriatric population are expected to boost the market growth in the coming years.

The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for acne medication. The global acne medication market is segmented on the basis of therapeutic class, route of administration, type, and region. By therapeutic class, the global acne medication market has been segmented into retinoids, antibiotics, hormonal agents, others. According to the research, the retinoids segment had the largest share in the global acne medication market. Based upon route of administration, the global acne medication market is categorized into topical, oral. In 2020, the topical segment made up the largest share of revenue generated by the acne medication market. On the basis of type, the global acne medication market has been segmented into prescription medicine, over-the-counter (OTC) medicine. Among these, the over-the-counter (OTC) medicine segment was accounted for the highest revenue generator in 2020. Geographically, the global acne medication market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global acne medication market is highly competitive. The prominent players operating in the global acne medication market include Allergan plc, Bausch Health Companies Inc., F. Hoffmann-la Roche Ltd., Galderma S.A. (Nestle S.A.), GlaxoSmithKline Plc (GSK), Mylan N.V., Perrigo Company plc, Pfizer Inc., Teva Pharmaceutical Industries Ltd.

Report Scope
Therapeutic class: retinoids, antibiotics, hormonal agents, others
Route of administration: topical, oral
Type: prescription medicine, over-the-counter (OTC) medicine
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2017 to 2027

Key Benefits for Stakeholders
Get a comprehensive picture of the global acne medication market
Pinpoint growth sectors and trends for investment

Contents

PART 1. INTRODUCTION

Scope of the study
Study period
Geographical scope
Research methodology

PART 2. ACNE MEDICATION MARKET OVERVIEW

PART 3. MARKET BREAKDOWN BY THERAPEUTIC CLASS

Retinoids
Antibiotics
Hormonal agents
Others

PART 4. MARKET BREAKDOWN BY ROUTE OF ADMINISTRATION

Topical
Oral

PART 5. MARKET BREAKDOWN BY TYPE

Prescription medicine
Over-the-counter (OTC) medicine

PART 6. MARKET BREAKDOWN BY REGION

North America
Asia Pacific
Europe
Rest of the World (ROW)

PART 7. KEY COMPANIES

Allergan plc
Bausch Health Companies Inc.
F. Hoffmann-la Roche Ltd.
Galderma S.A. (Nestle S.A.)
GlaxoSmithKline Plc (GSK)
Mylan N.V.
Perrigo Company plc
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
About StrategyHelix
Disclaimer